TAK-715 100mg 100mg | Purity Not Available
Adooq Bioscience
TAK 715 an inhibitor of p38 MAPK (IC50 = 7.1 nM for p38 MAPK??), Wnt/beta-catenin signaling, and Inhibits 22 kinases by more than 80%, including CK 1??/??.
More Information Supplier PageSearch Results
TAK-715 10mg 10mg | Purity Not Available
Adooq Bioscience
TAK 715 an inhibitor of p38 MAPK (IC50 = 7.1 nM for p38 MAPK??), Wnt/beta-catenin signaling, and Inhibits 22 kinases by more than 80%, including CK 1??/??.
More Information Supplier PageToceranib (PHA 291639, SU 11654) 50mg 50mg | Purity Not Available
Adooq Bioscience
Toceranib is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFR??.
More Information Supplier PageToceranib (PHA 291639, SU 11654) 5mg 5mg | Purity Not Available
Adooq Bioscience
Toceranib is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFR??.
More Information Supplier PageToceranib (PHA 291639, SU 11654) 25mg 25mg | Purity Not Available
Adooq Bioscience
Toceranib is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFR??.
More Information Supplier PageToceranib (PHA 291639, SU 11654) 10mg 10mg | Purity Not Available
Adooq Bioscience
Toceranib is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFR??.
More Information Supplier PageTegobuvir (GS-9190) 10mg 10mg | Purity Not Available
Adooq Bioscience
Tegobuvir (GS-9190) 25mg 25mg | Purity Not Available
Adooq Bioscience
TMC353121 25mg 25mg | Purity Not Available
Adooq Bioscience
TMC353121 is a potent RSV fusion inhibitor in vitro, Antiviral agents and a novel candidate for RSV disease treatment.
More Information Supplier PageTMC353121 10mg 10mg | Purity Not Available
Adooq Bioscience
TMC353121 is a potent RSV fusion inhibitor in vitro, Antiviral agents and a novel candidate for RSV disease treatment.
More Information Supplier Page